Credit Capital Investments’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-850
Closed -$237K 44
2025
Q2
$237K Hold
850
0.33% 38
2025
Q1
$265K Hold
850
0.45% 23
2024
Q4
$222K Hold
850
0.29% 28
2024
Q3
$274K Hold
850
0.34% 25
2024
Q2
$266K Hold
850
0.33% 23
2024
Q1
$242K Buy
+850
New +$249K 0.3% 31

Other funds holding AMGN

Credit Capital Investments's AMGN Position: Q3 2025 in Review

Credit Capital Investments sold out of Amgen (AMGN) in Q3 2025, closing a stake of 850 shares — an estimated $237K sold.

Credit Capital Investments first reported a position in AMGN in Q1 2024 and held it in 6 quarters. The position peaked at $274K in Q3 2024. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • Credit Capital Investments reported no remaining Amgen position as of Q3 2025 after selling out during the quarter.
  • Credit Capital Investments sold 850 Amgen shares in Q3 2025, an estimated $237K.
  • Credit Capital Investments first reported a position in Amgen in Q1 2024 and held it in 6 quarters.
  • Credit Capital Investments's Amgen position peaked at $274K in Q3 2024.
  • 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on Credit Capital Investments's 13F filing for Q3 2025, filed 14 Nov 2025.